Reaction to “How Much Is Life Worth” for cancer patients
Ought doctors to take drug costs into account when they advice advanced cancer patients? Peter Bach at Memorial Sloan Kettering reacts in this phone interview to a cost-conscious commentary “How Much is Life Worth?” in JNCI (Journal of the National Institute).
Listen to the podcast at JNCI
(You’ll need the QuickTime plug-in installed in your browser. It’s safe and free to download. Follow your browser’s instructions).
The article discussed is How Much Is Life Worth: Cetuximab, Non–Small Cell Lung Cancer, and the $440 Billion Question by Tito Fojo, Christine Grady, appeared June 29 2009.
This interview is a JNCI podcast.